Trillium Therapeutics

-$0.00 (-0.08%) As of 6:49 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRIL and other ETFs, options, and stocks.

About TRIL

Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system.

CEO

Jan Skvarka

Employees

—

Headquarters

Mississauga, Ontario

Founded

2004

TRIL Key Statistics

Market Cap

1.01B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

909.15K

High Today

$6.65

Low Today

$6.43

Open Price

$6.49

Volume

658.27K

52 Week High

$20.96

52 Week Low

$6.35

Analyst Ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

TRIL Earnings

-$1.07

-$0.22

$0.64

$1.49

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 16, After Hours